Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Found 311 studies with search of: | Open Studies | "Myeloproliferative Disorders" |
Rank | Status | Study | ||||
---|---|---|---|---|---|---|
1 | Recruiting |
Vorinostat, Cytarabine, and Etoposide in Treating Patients With Relapsed and/or Refractory Acute Leukemia or Myelodysplastic Syndromes or Myeloproliferative Disorders
|
||||
2 | Recruiting |
Fludarabine and Total-Body Irradiation Followed By a Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndromes or Myeloproliferative Disorders
|
||||
3 | Recruiting |
Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndrome, Acute Myeloid Leukemia, or Myeloproliferative Disorder
|
||||
4 | Recruiting |
Clofarabine and Cyclophosphamide in Treating Patients With Relapsed or Refractory Acute Leukemia, Chronic Myelogenous Leukemia, or Myeloproliferative Disorders
|
||||
5 | Recruiting |
T-Cell Recovery in Patients With Leukemia, Advanced Lymphoma, Myelodysplastic Syndrome, or Myeloproliferative Disorder Receiving Alemtuzumab and Undergoing Donor Stem Cell Transplant
|
||||
6 | Recruiting |
Evaluation of the Anti-CD-33 Immunotoxin Hum-195/rGel in Patients With Advanced Myeloid Malignancies
|
||||
7 | Recruiting |
Gene Changes and Biomarkers in Chronic Myeloproliferative Disorders
|
||||
8 | Recruiting |
3-AP and Fludarabine in Treating Patients With Myeloproliferative Disorders, Chronic Myelomonocytic Leukemia, or Accelerated Phase or Blastic Phase Chronic Myelogenous Leukemia
|
||||
9 | Recruiting |
Long-Term Follow-Up of Patients in First Remission Who Have Participated in Children's Oncology Group Studies
|
||||
10 | Recruiting |
Early Administration of Antithymocyte Globulin Followed By Cyclophosphamide, Busulfan, and Fludarabine Before a Donor Stem Cell Transplant in Treating Patients With Hematological Cancer or Kidney Cancer
|
||||
11 | Recruiting |
Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial
|
||||
12 | Recruiting |
Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer
|
||||
13 | Recruiting |
Alemtuzumab, Total-Body Irradiation, and Fludarabine Followed By Donor Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer
|
||||
14 | Recruiting |
T-Regulatory Cell Infusion After an Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer or Other Disorder
|
||||
15 | Recruiting |
Pegasys® in Patients With Myeloproliferative Diseases
|
||||
16 | Recruiting |
ABT-888 and Topotecan With or Without Carboplatin in Treating Patients With Relapsed or Refractory Acute Leukemia, High-Risk Myelodysplasia, or Aggressive Myeloproliferative Disorders
|
||||
17 | Recruiting |
Caregiver Support in the Quality of Life of Patients Who Are Undergoing Donor Bone Marrow Transplantation
|
||||
18 | Recruiting |
Immunologic Diagnostic Blood Test in Predicting Side-Effects in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Other Diseases
|
||||
19 | Recruiting |
Beclomethasone in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant for Hematologic Cancer
|
||||
20 | Recruiting |
Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
|
Previous Page | Studies Shown (1-20) | Next (21-40) |